Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Alzheimer's crawled date : 2021 - 11 - 11 save search
Eisai Presents New Analysis Of Lecanemab Clinical Efficacy Results From Phase 2b Study At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-11 (Crawled : 20:00) - biospace.com/
BIIB | $192.16 -1.53% -1.57% 1.1M
|
Health Technology
|
| O: -0.12%
H: 0.37%
C: -0.02%
disease alzheimer ema phase 2 clinical trials results trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's lecanemab
New Blood Test To Identify People At Risk Of Developing Alzheimer's Symptoms Will Be Used In Clinical Trial Aiming To Prevent Memory Loss
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
BIIB | $192.16 -1.53% -1.57% 1.1M
|
Health Technology
|
| O: -0.12%
H: 0.37%
C: -0.02%
alzheimer blood risk test trial alzheimer’s alzheimer's
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.